Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT00202371

Transfusion Effects in Myelodysplastic Patients: Limiting Exposure

Transfusion Effects in Myelodysplastic Patients: Limiting Exposure (Temple)

Status
Withdrawn
Phase
Phase 4
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Sanquin Research & Blood Bank Divisions · Academic / Other
Sex
All
Age
Healthy volunteers
Accepted

Summary

The goal of this study was to compare a restrictive RBC transfusion policy (a Hb transfusion trigger: 7.2 gr/dl) with a more liberal RBC transfusion policy (a Hb transfusion trigger: 9.6 gr/dl) on physical fatigue.

Detailed description

The goal of this study was to compare a restrictive RBC transfusion policy (a Hb transfusion trigger of 7.2 gr/dl) with a more liberal RBC transfusion policy (a Hb transfusion trigger of 9.6 gr/dl) on physical fatigue.

Conditions

Interventions

TypeNameDescription
PROCEDURERed Blood Cell transfusion

Timeline

Start date
2002-07-01
Completion
2005-07-01
First posted
2005-09-20
Last updated
2023-11-24

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT00202371. Inclusion in this directory is not an endorsement.